Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: Takeda NDA triggers milestone

By admin

Created Feb 29 2008 - 6:59am

The FDA has accepted Takeda Pharmaceutical's NDA for alogliptin, a DPP-4 inhibitor for type 2 diabetes. The FDA's acceptance of the NDA filing triggers a $15 million milestone payment to PPD. Release [1]

Diabetes
FDA
milestones
Type 2 Diabetes

Source URL: http://www.fiercebiotech.com/story/spotlight-takeda-nda-triggers-milestone/2008-02-29

Links:
[1] http://www.fiercebiotech.com/press-releases/ppd-confirms-takeda-pharmaceuticals-nda-filing-alogliptin-fda-triggers-15m-milestone-